Improved Methods for Pharmacometric Model-Based Decision-Making in Clinical Drug Development
Pharmacometric model-based analysis using nonlinear mixed-effects models (NLMEM) has to date mainly been applied to learning activities in drug development. However, such analyses can also serve as the primary analysis in confirmatory studies, which is expected to bring higher power than traditional...
Main Author: | Dosne, Anne-Gaëlle |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Uppsala universitet, Institutionen för farmaceutisk biovetenskap
2016
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-305697 http://nbn-resolving.de/urn:isbn:978-91-554-9734-7 |
Similar Items
-
Novel Pharmacometric Methods for Informed Tuberculosis Drug Development
by: Clewe, Oskar
Published: (2016) -
Novel pharmacometric methods to improve clinical drug development in progressive diseases
by: Buatois, Simon
Published: (2018) -
Development, Application and Evaluation of Statistical Tools in Pharmacometric Data Analysis
by: Lindbom, Lars
Published: (2006) -
Pharmacometrics as an instrument of clinical pharmacology for optimization of drugs dosing regimens during pregnancy
by: Reshetko O.V., et al.
Published: (2014-03-01) -
Application of Pharmacometric Methods to Improve Pediatric Drug Development
by: Lala, Mallika
Published: (2011)